Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Biochimica Et Biophysica Acta|August 29, 2003
Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human astrocytoma cells by the pyrrolo-1,5-benzoxazepine, PBOX-21Jude M Mulligan, Giuseppe Campiani, Anna Ramunno, et al.Biochimica Et Biophysica Acta|August 19, 2008
Interaction between Alzheimer's Abeta(25-35) peptide and phospholipid bilayers: the role of cholesterolGerardino D'Errico, Giuseppe Vitiello, Ornella Ortona, et al.Bioorganic & Medicinal Chemistry|June 27, 2008
Novel sterically hindered cannabinoid CB1 receptor ligandsPaolo Urbani, Maria Grazia Cascio, Anna Ramunno, et al.Bioorganic & Medicinal Chemistry Letters|July 26, 2005
3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligandsMałgorzata Dukat, Anna Ramunno, Rita Banzi, et al.FEBS Letters|April 12, 2002
Caspase-3 is not essential for DNA fragmentation in MCF-7 cells during apoptosis induced by the pyrrolo-1,5-benzoxazepine, PBOX-6Margaret M Mc Gee, Edel Hyland, Giuseppe Campiani, et al.Current Pharmaceutical Design|April 12, 2002
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectivesGiuseppe Campiani, Anna Ramunno, Giovanni Maga, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|January 12, 2010
Interaction of a beta-sheet breaker peptide with lipid membranesGiuseppe Vitiello, Manuela Grimaldi, Anna Ramunno, et al.The Journal of Biological Chemistry|February 22, 2002
Activation of the c-Jun N-terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cellsMargaret M Mc Gee, Giuseppe Campiani, Anna Ramunno, et al.Bioorganic & Medicinal Chemistry Letters|June 1, 2005
6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligandAnna Ramunno, Małgorzata Dukat, Mase Lee, et al.Antimicrobial Agents and Chemotherapy|April 24, 2004
Effects of drug resistance mutations L100I and V106A on the binding of pyrrolobenzoxazepinone nonnucleoside inhibitors to the human immunodeficiency virus type 1 reverse transcriptase catalytic complexGiada A Locatelli, Giuseppe Campiani, Reynel Cancio, et al.Pageof 5